Home
Nykode Therapeutics

Nykode Therapeutics Market Share Analysis for May 2026

We are proud to have multiple product candidates developed by Nykode in our pipeline.See what's going on!

Industry: N/A

Domainnykode.com

Year Founded2007

Employees51 - 200

Annual Revenue$10M - $15M

Nykode Therapeutics

Nykode Therapeutics (including company regionals)

nykode.com

See more website traffic and engagement information

Nykode Therapeutics Revenue up to May 2026 is 10M - 15M

revenue generated by Nykode Therapeutics top domains

Nykode Therapeutics top domains revenue over 3 years

Revenue for Nykode Therapeutics top domains

nykode.com10M - 15M

See more with Sales Intelligence

Total visits to Nykode Therapeutics's top domains

Understand Nykode Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nykode.com5.7K

See more with Sales Intelligence

Avg. visit duration in Nykode Therapeutics's top domains

Analyze Nykode Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nykode.com00:00:16

See more with Sales Intelligence

Avg. pageviews on Nykode Therapeutics's top domains

See how Nykode Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nykode.com1.90

See more with Sales Intelligence

Nykode Therapeutics top competitors by domain

Top similar sites in May 2026, ranked by their affinity

fda.govCompany NameFDAEmployees> 10001HQUnited States, Maryland, Silver SpringAnnual revenue> $1BTotal visits7MHealth > Pharmacy

Top technologies used by Nykode Therapeutics

These are the website technologies, by industry, used by Nykode Therapeutics top domains

Mobile (3)

Meta Viewport

Widget (3)

Twemoji

Audio Video Media (1)

Vimeo

Content Management System (1)

WordPress

More Technologies

6

See all

News & Signals from Nykode Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNykode Therapeutics AS hires Barbara Krebs-Pohl as chair and approves board remuneration.Nykode Therapeutics appoints Barbara Krebs-Pohl as chair and approves board remuneration.

NewsNykode Therapeutics AS will attend event 10th International Congress on Innovative Approaches in Head & Neck Oncology on Mar 20th '26.Oslo, Norway, December 19, 2025 - Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced the oral presentation of interim data from the VB-C-03 trial at the 10th International Congress on Innovative Approaches in Head & Neck Oncology (ICHNO) on March 20, 2026.

NewsNykode Therapeutics AS attends event 2025 ASCO Annual Meeting.Nykode Therapeutics highlights new data in two Poster presentations at the 2025 ASCO Annual Meeting.